Anil K Tyagi Selected Research

Infections

1/2018	An attenuated quadruple gene mutant of Mycobacterium tuberculosis imparts protection against tuberculosis in guinea pigs.
7/2015	Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
1/2013	Secretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs.
2/2012	Iron storage proteins are essential for the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infection.
1/2008	Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anil K Tyagi Research Topics

Disease

37	Tuberculosis (Tuberculoses) 01/2019 - 08/2001
8	Neoplasms (Cancer) 12/2004 - 03/2002
5	Infections 01/2018 - 01/2008
5	Carcinoma (Carcinomatosis) 02/2004 - 06/2002
3	Prostatic Neoplasms (Prostate Cancer) 02/2004 - 06/2002
2	Pulmonary Tuberculosis 12/2017 - 01/2013
2	Leprosy (Hansen's Disease) 07/2009 - 10/2007
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2007 - 12/2003
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2007 - 02/2003
2	Breast Neoplasms (Breast Cancer) 05/2004 - 02/2004
2	Papilloma (Papillomatosis) 12/2003 - 03/2002
1	Hypoxia (Hypoxemia) 01/2017
1	Lung Diseases (Lung Disease) 07/2015
1	Disease Progression 10/2013
1	Extensively Drug-Resistant Tuberculosis 01/2013
1	Communicable Diseases (Infectious Diseases) 10/2012
1	HIV Infections (HIV Infection) 02/2011
1	Dehydration (Water Stress) 02/2010
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 07/2009
1	Fibrosis (Cirrhosis) 01/2008
1	Granuloma 01/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2004

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 12/2017 - 01/2003
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2001
8	Pharmaceutical PreparationsIBA 01/2019 - 11/2002
7	AntigensIBA 12/2017 - 03/2005
7	Silybin (Lagosa)IBA 12/2004 - 03/2002
5	Biological ProductsIBA 01/2014 - 03/2002
4	EnzymesIBA 01/2014 - 08/2001
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2004 - 11/2002
3	BCG Vaccine FDA Link 01/2017 - 01/2008
3	DNA VaccinesIBA 07/2015 - 12/2005
3	Antitubercular AgentsIBA 01/2011 - 11/2009
3	milk-thistle extractIBA 12/2003 - 06/2002
3	SilymarinIBA 11/2003 - 03/2002
2	Crystallins (Crystallin)IBA 12/2017 - 01/2013
2	Dihydrotachysterol (AT 10)IBA 06/2014 - 01/2008
2	EndonucleasesIBA 01/2014 - 01/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013 - 09/2005
2	LipidsIBA 01/2013 - 03/2011
2	Acid PhosphataseIBA 01/2013 - 01/2013
2	Indicators and Reagents (Reagents)IBA 10/2012 - 01/2003
2	Ferritins (Ferritin)IBA 02/2012 - 04/2011
2	bacterioferritinIBA 02/2012 - 04/2011
2	Mycolic Acids (Mycolic Acid)IBA 03/2011 - 06/2005
2	Biotin (Vitamin H)FDA Link 03/2011 - 02/2010
2	Ligases (Synthetase)IBA 03/2011 - 02/2010
2	AerosolsIBA 12/2009 - 01/2008
2	AntibodiesIBA 11/2005 - 03/2005
2	flavanoneIBA 12/2004 - 12/2003
2	Grape Seed ExtractIBA 05/2004 - 02/2004
2	Cytotoxins (Cytolysins)IBA 05/2004 - 02/2004
2	Insulin-Like PeptidesIBA 02/2004 - 06/2002
2	FlavonoidsIBA 11/2003 - 06/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	ProteomeIBA 11/2014
1	PotassiumIBA 12/2013
1	mycobactinsIBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Exonucleases (3' 5' Exonuclease)IBA 01/2013
1	Tuberculosis VaccinesIBA 01/2013
1	PhosphotyrosineIBA 01/2013
1	DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA 01/2013
1	exodeoxyribonuclease IIIIBA 01/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2013
1	Deoxyribonuclease IV (Phage T4-Induced)IBA 01/2013
1	OligonucleotidesIBA 10/2012
1	IronIBA 02/2012
1	Superoxide DismutaseIBA 10/2011
1	thiamin phosphate synthaseIBA 01/2011
1	biotin carboxyl carrier proteinIBA 02/2010
1	LigandsIBA 02/2010
1	Proline (L-Proline)FDA Link 02/2010
1	A-Form DNA (A-DNA)IBA 12/2009
1	Immunologic Factors (Immunomodulators)IBA 07/2009
1	InterferonsIBA 01/2008
1	rBCG85C vaccineIBA 01/2008
1	InterleukinsIBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2008
1	CytokinesIBA 01/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2008
1	Tyrosine (L-Tyrosine)FDA Link 09/2005
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2005
1	Phosphotransferases (Kinase)IBA 05/2005
1	AnthracyclinesIBA 12/2004
1	NF-kappa B (NF-kB)IBA 12/2004
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 07/2004
1	Guanosine Diphosphate (GDP)IBA 07/2004
1	Guanosine Triphosphate (GTP)IBA 07/2004
1	Estrogen ReceptorsIBA 05/2004
1	Hormones (Hormone)IBA 02/2004
1	Insulin-Like Growth Factor Binding Protein 3IBA 02/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2013 - 05/2004
1	Immunotherapy 01/2013
1	Therapeutics 10/2012